Logo
x

Search

Subscribe Now

terminate

Merck KGaA and GSK Terminate their ~$4.2B Collaboration Due to Clinical Failures

Merck KGaA and GSK Terminate their ~$4.2B Collaboration Due to Clinical Failures

  • October 4, 2021
Helsinn and MEI Terminate its P-III Study of Pracinostat for Patients with AML

Helsinn and MEI Terminate its P-III Study of Pracinostat for Patients with AML

  • July 3, 2020
EMD Serono and Pfizer to Terminate P-III JAVELIN Head and Neck 100 Study Evaluating Bavencio + CRT for Squamous Cell Carcinoma of the Head and Neck

EMD Serono and Pfizer to Terminate P-III JAVELIN Head and Neck 100 Study Evaluating Bavencio + CRT for Squamous Cell Carcinoma of...

  • March 13, 2020
Chugai and Sanofi to Terminate their Licensing Agreement for Tofogliflozin Hydrate in Japan

Chugai and Sanofi to Terminate their Licensing Agreement for Tofogliflozin Hydrate in Japan

  • February 18, 2020
SanBio and Sumitomo Dainippon Pharma Terminate Joint Development and License Agreement for SB623 in North America

SanBio and Sumitomo Dainippon Pharma Terminate Joint Development and License Agreement for SB623 in North America

  • December 16, 2019
MorphoSys and Galapagos in Collaboration with Novartis Terminate Clinical Development of MOR106 in Atopic Dermatitis

MorphoSys and Galapagos in Collaboration with Novartis Terminate Clinical Development of MOR106 in Atopic Dermatitis

  • October 29, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.